(Q53588405)

English

Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.

scientific article published in October 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

0 references

sodium stibogluconate

1 reference

based on heuristic

inferred from title

meglumine antimoniate

1 reference

based on heuristic

inferred from title

Marleen Boelaert

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

author name string

Bermúdez H

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Rojas E

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Garcia L

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Desjeux P

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Dujardin JC

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Chappuis F

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Annals of Tropical Medicine and Parasitology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

100

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

591-600

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Sodium stibogluconate cardiotoxicity and safety of generics

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania brasiliensis brasiliensis

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

A new focus of cutaneous leishmaniasis due to Leishmania amazonensis in a Sub Andean region of Bolivia

1 reference

https://api.crossref.org/works/10.1179%2F136485906X118495

21 January 2018

Identifiers

10.1179/136485906X118495

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16989685

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53588405&oldid=1562763596"